Cost-effectiveness of Tocilizumab in Severe Coronavirus Disease 2019: to See or Not to See
Author(s) -
Lauren Pischel,
George Goshua
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab459
Subject(s) - tocilizumab , covid-19 , medicine , coronavirus , disease , virology , intensive care medicine , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom